{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:06:13Z","timestamp":1790658373180,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":1401,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.micinf.2020.01.003","type":"journal-article","created":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T02:07:49Z","timestamp":1580522869000},"page":"74-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":256,"title":["Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China"],"prefix":"10.1016","volume":"22","author":[{"given":"Fei","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanying","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Ojcius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chungen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibo","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2020.01.003_bib3","first-page":"130","article-title":"Cross-reactive antibodies in convalescent SARS patients\u2019 sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests","volume":"67","author":"Chan","year":"2013","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.micinf.2020.01.003_bib4","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/infdis\/jit589","article-title":"Investigation of anti-middle East respiratory syndrome antibodies in blood donors and slaughterhouse workers in Jeddah and Makkah, Saudi Arabia, fall 2012","volume":"209","author":"Aburizaiza","year":"2014","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2020.01.003_bib5","doi-asserted-by":"crossref","first-page":"20441","DOI":"10.2807\/1560-7917.ES2013.18.14.20441","article-title":"Specific serology for emerging human coronaviruses by protein microarray","volume":"18","author":"Reusken","year":"2013","journal-title":"Euro Surveill"},{"key":"10.1016\/j.micinf.2020.01.003_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/1743-422X-10-266","article-title":"A\u00a0safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV","volume":"10","author":"Zhao","year":"2013","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2020.01.003_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25678","article-title":"Outbreak of pneumonia of unknown etiology in Wuhan China: the mystery and the miracle","volume":"92","author":"Lu","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.micinf.2020.01.003_bib8","unstructured":"WHO: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/clinical-management-of-novel-cov.pdf?sfvrsn=bc7da517_2."},{"key":"10.1016\/j.micinf.2020.01.003_bib9","unstructured":"WHO: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/20200114-interim-laboratory-guidance-version.pdf?sfvrsn=6967c39b_4&download=true."},{"key":"10.1016\/j.micinf.2020.01.003_bib10","unstructured":"https:\/\/www.gisaid.org\/."},{"key":"10.1016\/j.micinf.2020.01.003_bib11","unstructured":"http:\/\/virological.org\/t\/initial-assessment-of-the-ability-of-published-coronavirus-primers-sets-to-detect-the-wuhan-coronavirus\/321."},{"key":"10.1016\/j.micinf.2020.01.003_bib12","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1007\/s00705-017-3281-9","article-title":"Simultaneous detection of severe acute respiratory syndrome, Middle East respiratory syndrome, and related bat coronaviruses by real-time reverse transcription PCR","volume":"162","author":"Noh","year":"2017","journal-title":"Arch Virol"},{"key":"10.1016\/j.micinf.2020.01.003_bib13","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.jmoldx.2017.06.007","article-title":"Evaluation and clinical validation of two field-deployable reverse transcription-insulated isothermal PCR assays for the detection of the Middle East respiratory syndrome-coronavirus","volume":"19","author":"Go","year":"2017","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.micinf.2020.01.003_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1128\/JCM.02533-13","article-title":"Real-time reverse transcription-PCR assay panel for Middle East respiratory syndrome coronavirus","volume":"52","author":"Lu","year":"2014","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.micinf.2020.01.003_bib15","doi-asserted-by":"crossref","first-page":"20285","DOI":"10.2807\/ese.17.39.20285-en","article-title":"Detection of a novel human coronavirus by real-time reverse-transcription polymerase chain reaction","volume":"17","author":"Corman","year":"2012","journal-title":"Euro Surveill"},{"key":"10.1016\/j.micinf.2020.01.003_bib16","doi-asserted-by":"crossref","first-page":"e23874","DOI":"10.5812\/ircmj.23874","article-title":"Development of dual TaqMan based one-step rRT-PCR assay panel for rapid and accurate diagnostic test of MERS-CoV: a novel human coronavirus, ahead of Hajj pilgrimage","volume":"18","author":"Hashemzadeh","year":"2016","journal-title":"Iran Red Crescent Med J"},{"key":"10.1016\/j.micinf.2020.01.003_bib17","unstructured":"WHO: https:\/\/www.who.int\/docs\/default-source\/coronaviruse\/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf?sfvrsn=d381fc88_2."},{"key":"10.1016\/j.micinf.2020.01.003_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/1743-422X-11-139","article-title":"Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP)","volume":"11","author":"Shirato","year":"2014","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2020.01.003_bib19","first-page":"2166","article-title":"One-pot reverse transcriptional loop-mediated isothermal amplification (RT-LAMP) for detecting MERS-CoV","volume":"7","author":"Lee","year":"2016","journal-title":"Front Microbiol"},{"key":"10.1016\/j.micinf.2020.01.003_bib20","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.3389\/fmicb.2018.01101","article-title":"A\u00a0rapid and specific assay for the detection of MERS-CoV","volume":"9","author":"Huang","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.micinf.2020.01.003_bib21","article-title":"Reverse transcription recombinase polymerase amplification assay for the detection of middle East respiratory syndrome coronavirus","volume":"5","author":"Abd El Wahed","year":"2013","journal-title":"PLoS Curr"},{"key":"10.1016\/j.micinf.2020.01.003_bib22","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.3389\/fmicb.2017.01510","article-title":"Establishment and application of a universal coronavirus screening method using MALDI-TOF mass spectrometry","volume":"8","author":"Xiu","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.micinf.2020.01.003_bib23","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bios.2018.08.007","article-title":"Arch-shaped multiple-target sensing for rapid diagnosis and identification of emerging infectious pathogens","volume":"119","author":"Koo","year":"2018","journal-title":"Biosens Bioelectron"},{"issue":"10","key":"10.1016\/j.micinf.2020.01.003_bib24","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.1021\/acs.analchem.7b00255","article-title":"Multiplex paper-based colorimetric DNA sensor using Pyrrolidinyl peptide nucleic acid-induced AgNPs aggregation for detecting MERS-CoV, MTB, and HPV Oligonucleotides","volume":"89","author":"Teengam","year":"2017","journal-title":"Anal Chem"},{"key":"10.1016\/j.micinf.2020.01.003_bib25","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature12005","article-title":"Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC","volume":"495","author":"Raj","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2020.01.003_bib26","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2020.01.003_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1586\/14760584.2014.912134","article-title":"Current advancements and potential strategies in the development of MERS-CoV vaccines","volume":"13","author":"Zhang","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.micinf.2020.01.003_bib28","doi-asserted-by":"crossref","first-page":"e44874","DOI":"10.1371\/journal.pone.0044874","article-title":"The conserved residue Arg46 in the N-terminal heptad repeat domain of HIV-1 gp41 is critical for viral fusion and entry","volume":"7","author":"Wang","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.micinf.2020.01.003_bib29","doi-asserted-by":"crossref","first-page":"E60","DOI":"10.3390\/v11010060","article-title":"Advances in MERS-CoV vaccines and therapeutics based on the receptor-binding domain","volume":"11","author":"Zhou","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.micinf.2020.01.003_bib30","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1080\/21645515.2016.1177688","article-title":"Immunization with inactivated Middle East Respiratory Syndrome coronavirus vaccine leads to lung immunopathology on challenge with live virus","volume":"12","author":"Agrawal","year":"2016","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.micinf.2020.01.003_bib31","doi-asserted-by":"crossref","first-page":"6551","DOI":"10.1128\/JVI.00087-13","article-title":"Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein","volume":"87","author":"Fett","year":"2013","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.01.003_bib32","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.vaccine.2007.11.092","article-title":"Chimeric coronavirus-like particles carrying severe acute respiratory syndrome coronavirus (SCoV) S protein protect mice against challenge with SCoV","volume":"26","author":"Lokugamage","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2020.01.003_bib33","doi-asserted-by":"crossref","first-page":"6606","DOI":"10.1016\/j.vaccine.2011.06.111","article-title":"Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV","volume":"29","author":"Liu","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2020.01.003_bib34","doi-asserted-by":"crossref","first-page":"8651","DOI":"10.1128\/JVI.00614-15","article-title":"Protective efficacy of recombinant modified vaccinia virus Ankara delivering Middle East respiratory syndrome coronavirus spike glycoprotein","volume":"89","author":"Volz","year":"2015","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.01.003_bib35","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41541-017-0029-1","article-title":"Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model","volume":"2","author":"Munster","year":"2017","journal-title":"npj Vaccines"},{"key":"10.1016\/j.micinf.2020.01.003_bib36","first-page":"348","article-title":"Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC","volume":"67","author":"Du","year":"2013","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.micinf.2020.01.003_bib37","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.vaccine.2017.02.063","article-title":"DNA vaccine encoding Middle East respiratory syndrome coronavirus S1 protein induces protective immune responses in mice","volume":"35","author":"Chi","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2020.01.003_bib38","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1016\/j.vaccine.2008.09.026","article-title":"A\u00a0SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial","volume":"26","author":"Martin","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.micinf.2020.01.003_bib39","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/S1473-3099(19)30266-X","article-title":"Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial","volume":"19","author":"Modjarrad","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.micinf.2020.01.003_bib40","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.antiviral.2016.11.006","article-title":"T-cell immunity of SARS-CoV: implications for vaccine development against MERS-CoV","volume":"137","author":"Liu","year":"2017","journal-title":"Antivir Res"},{"key":"10.1016\/j.micinf.2020.01.003_bib41","doi-asserted-by":"crossref","first-page":"15092","DOI":"10.1038\/ncomms15092","article-title":"Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains","volume":"8","author":"Yuan","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.micinf.2020.01.003_bib42","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1517\/14712598.2015.1092518","article-title":"Middle East respiratory syndrome: current status and future prospects for vaccine development","volume":"15","author":"Du","year":"2015","journal-title":"Expet Opin Biol Ther"},{"key":"10.1016\/j.micinf.2020.01.003_bib43","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from patients with acute respiratory disease in Wuhan, Hubei, China","volume":"9","author":"Chen","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.micinf.2020.01.003_bib44","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2020.1723441","article-title":"An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies","volume":"9","author":"Jiang","year":"2020","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.micinf.2020.01.003_bib45","doi-asserted-by":"crossref","first-page":"e02002","DOI":"10.1128\/JVI.02002-17","article-title":"Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on the Middle East respiratory syndrome coronavirus spike glycoprotein to avoid neutralization escape","volume":"92","author":"Wang","year":"2018","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.01.003_bib46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0378-1135(93)90126-R","article-title":"A\u00a0review of feline infectious peritonitis virus: molecular biology, immunopathogenesis, clinical aspects, and vaccination","volume":"36","author":"Olsen","year":"1993","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.micinf.2020.01.003_bib47","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.omtm.2019.03.006","article-title":"The impact of pre-existing immunity on the non-clinical pharmacodynamics of AAV5-based gene therapy","volume":"13","author":"Long","year":"2019","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.micinf.2020.01.003_bib48","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bbrc.2004.09.106","article-title":"Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine","volume":"324","author":"He","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.micinf.2020.01.003_bib49","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.bbrc.2004.10.052","article-title":"Inactivated SARS-CoV vaccine elicits high titers of spike protein-specific antibodies that block receptor binding and virus entry","volume":"325","author":"He","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.micinf.2020.01.003_bib50","doi-asserted-by":"crossref","first-page":"4908","DOI":"10.4049\/jimmunol.174.8.4908","article-title":"Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies","volume":"174","author":"He","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2020.01.003_bib51","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.virol.2005.01.034","article-title":"Identification of a critical neutralization determinant of severe acute respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccines","volume":"334","author":"He","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.micinf.2020.01.003_bib52","doi-asserted-by":"crossref","first-page":"6085","DOI":"10.4049\/jimmunol.176.10.6085","article-title":"Cross-neutralization of human and palm civet severe acute respiratory syndrome coronaviruses by antibodies targeting the receptor-binding domain of spike protein","volume":"176","author":"He","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2020.01.003_bib53","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1007\/s11427-017-9189-3","article-title":"Cross-neutralization of SARS coronavirus-specific antibodies against bat SARS-like coronaviruses","volume":"60","author":"Zeng","year":"2017","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.micinf.2020.01.003_bib54","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4161\/hv.27464","article-title":"Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate","volume":"10","author":"Chen","year":"2014","journal-title":"Hum Vaccines Immunother"},{"key":"10.1016\/j.micinf.2020.01.003_bib55","unstructured":"http:\/\/www.smetimes.in\/smetimes\/news\/global-business\/2020\/Jan\/23\/china-us-vaccine50374.html."},{"key":"10.1016\/j.micinf.2020.01.003_bib56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.antiviral.2018.09.009","article-title":"The WHO R&D Blueprint: 2018 review of emerging infectious diseases requiring urgent research and development efforts","volume":"159","author":"Mehand","year":"2018","journal-title":"Antivir Res"},{"key":"10.1016\/j.micinf.2020.01.003_bib57","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1007\/s40265-017-0830-1","article-title":"Middle East respiratory syndrome and severe acute respiratory syndrome: current therapeutic options and potential targets for novel therapies","volume":"77","author":"Dyall","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.micinf.2020.01.003_bib58","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/365113a0","article-title":"HIV-1 inhibition by a peptide","volume":"365","author":"Jiang","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2020.01.003_bib59","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0140-6736(04)15788-7","article-title":"Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors","volume":"363","author":"Liu","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.micinf.2020.01.003_bib60","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1038\/ncomms4067","article-title":"Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor","volume":"5","author":"Lu","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.micinf.2020.01.003_bib61","doi-asserted-by":"crossref","first-page":"eaav4580","DOI":"10.1126\/sciadv.aav4580","article-title":"A\u00a0pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike","volume":"5","author":"Xia","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.micinf.2020.01.003_bib62","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.1073\/pnas.0403492101","article-title":"Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity","volume":"101","author":"Buchholz","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 4","key":"10.1016\/j.micinf.2020.01.003_bib63","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1099\/0022-1317-74-4-745","article-title":"Identification of antigenic sites mediating antibody-dependent enhancement of feline infectious peritonitis virus infectivity","volume":"74","author":"Olsen","year":"1993","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.micinf.2020.01.003_bib64","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","article-title":"Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in\u00a0vitro escape mutants","volume":"79","author":"Bakker","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2020.01.003_bib65","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.antiviral.2016.06.003","article-title":"Single-dose treatment with a humanized neutralizing antibody affords full protection of a human transgenic mouse model from lethal Middle East respiratory syndrome (MERS)-coronavirus infection","volume":"132","author":"Qiu","year":"2016","journal-title":"Antivir Res"},{"key":"10.1016\/j.micinf.2020.01.003_bib66","doi-asserted-by":"crossref","first-page":"8738","DOI":"10.1073\/pnas.1510830112","article-title":"Pre- and postexposure efficacy of fully human antibodies against Spike protein in a novel humanized mouse model of MERS-CoV infection","volume":"112","author":"Pascal","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2020.01.003_bib67","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/nm1080","article-title":"An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus","volume":"10","author":"Traggiai","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.micinf.2020.01.003_bib68","doi-asserted-by":"crossref","first-page":"10473","DOI":"10.1073\/pnas.1510199112","article-title":"Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus","volume":"112","author":"Corti","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2020.01.003_bib69","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/infdis\/jix209","article-title":"Human neutralizing monoclonal antibody inhibition of Middle East respiratory syndrome coronavirus replication in the common Marmoset","volume":"215","author":"Chen","year":"2017","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2020.01.003_bib70","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1080\/22221751.2019.1624482","article-title":"Antibodies and vaccines against Middle East respiratory syndrome coronavirus","volume":"8","author":"Xu","year":"2019","journal-title":"Emerg Microb Infect"},{"key":"10.1016\/j.micinf.2020.01.003_bib71","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/rmv.706","article-title":"Neutralizing human monoclonal antibodies to severe acute respiratory syndrome coronavirus: target, mechanism of action, and therapeutic potential","volume":"22","author":"Coughlin","year":"2012","journal-title":"Rev Med Virol"},{"key":"10.1016\/j.micinf.2020.01.003_bib72","doi-asserted-by":"crossref","first-page":"E2018","DOI":"10.1073\/pnas.1402074111","article-title":"Identification of human neutralizing antibodies against MERS-CoV and their role in virus adaptive evolution","volume":"111","author":"Tang","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2020.01.003_bib73","doi-asserted-by":"crossref","first-page":"e1000197","DOI":"10.1371\/journal.ppat.1000197","article-title":"Broadening of neutralization activity to directly block a dominant antibody-driven SARS-coronavirus evolution pathway","volume":"4","author":"Sui","year":"2008","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.micinf.2020.01.003_bib74","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S1473-3099(14)70920-X","article-title":"Ribavirin and interferon alfa-2a for severe Middle East respiratory syndrome coronavirus infection: a retrospective cohort study","volume":"14","author":"Omrani","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.micinf.2020.01.003_bib75","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aal3653","article-title":"Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses","volume":"9","author":"Sheahan","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.micinf.2020.01.003_bib76","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1177\/1060028015597449","article-title":"Oral ribavirin for the treatment of noninfluenza respiratory viral infections: a systematic review","volume":"49","author":"Gross","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.micinf.2020.01.003_bib77","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1136\/thorax.2003.012658","article-title":"Role of lopinavir\/ritonavir in the treatment of SARS: initial virological and clinical findings","volume":"59","author":"Chu","year":"2004","journal-title":"Thorax"},{"key":"10.1016\/j.micinf.2020.01.003_bib78","first-page":"606","article-title":"Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus","volume":"67","author":"Chan","year":"2013","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.micinf.2020.01.003_bib79","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1001\/jama.290.24.3222","article-title":"Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study","volume":"290","author":"Loutfy","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.micinf.2020.01.003_bib80","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.tree.2007.11.010","article-title":"Pacing a small cage: mutation and RNA viruses","volume":"23","author":"Belshaw","year":"2008","journal-title":"Trends Ecol Evol"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457920300253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457920300253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:37:00Z","timestamp":1761143820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457920300253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":78,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S1286457920300253"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2020.01.003","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measures for diagnosing and treating infections by a novel coronavirus responsible for a pneumonia outbreak originating in Wuhan, China","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2020.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}